CSF & Blood-Brain Barrier
CSF & Blood-Brain Barrier
What Do You Need to Know?
- CSF production & circulation — choroid plexus (70%), total volume ~150 mL, production ~500 mL/day, turned over 3–4×/day; flow: lateral ventricles → foramen of Monro → 3rd ventricle → aqueduct of Sylvius → 4th ventricle → Luschka/Magendie → subarachnoid space → arachnoid granulations → superior sagittal sinus
- Normal CSF values — opening pressure 10–20 cmH2O, protein 15–45 mg/dL, glucose >60% serum, WBC <5 lymphocytes, RBC 0, clear & colorless
- CSF in disease — bacterial (PMNs, ↓↓glucose, ↑↑protein), viral (lymphocytes, normal glucose), TB/fungal (lymphocytes, ↓glucose), GBS (albuminocytologic dissociation), MS (oligoclonal bands, ↑IgG index), SAH (xanthochromia)
- Hydrocephalus — communicating vs obstructive; NPH triad (wet–wacky–wobbly); pseudotumor cerebri/IIH (young obese women, papilledema, empty sella)
- Blood-brain barrier — endothelial tight junctions + basement membrane + astrocyte foot processes; lipophilic/small/uncharged molecules cross; circumventricular organs LACK BBB (area postrema, median eminence, neurohypophysis, pineal, subfornical organ, OVLT)
- BBB disruption — infection, tumors, ischemia → contrast enhancement on MRI = BBB breakdown
- Lumbar puncture — contraindications (mass with midline shift, coagulopathy), complications (post-LP headache, herniation)
CSF Production
Sources & Basic Parameters
- Choroid plexus — produces ~70% of CSF; located in lateral, 3rd, and 4th ventricles (most in lateral ventricles)
- Brain parenchyma (interstitial fluid) — contributes ~30%
- Total CSF volume: ~150 mL (adults)
- Production rate: ~20 mL/hr (~500 mL/day)
- Turnover: entire volume replaced 3–4×/day
- Mechanism: active secretion (NOT ultrafiltration) — Na+/K+ ATPase on apical membrane of choroid epithelium drives ion transport; carbonic anhydrase involved; acetazolamide ↓ CSF production by inhibiting carbonic anhydrase
CSF is actively secreted, not passively filtered. Acetazolamide reduces CSF production by inhibiting carbonic anhydrase in the choroid plexus — this is the basis for its use in idiopathic intracranial hypertension (IIH).
CSF Circulation Pathway
Flow Path
- Lateral ventricles (largest; C-shaped)
- → Foramen of Monro (interventricular foramina) → 3rd ventricle
- → Aqueduct of Sylvius (cerebral aqueduct; narrowest point — most common site of obstruction) → 4th ventricle
- → Exits via foramina of Luschka (lateral, 2) and foramen of Magendie (midline, 1)
- → Subarachnoid space (cisterns: cisterna magna, prepontine, suprasellar, etc.)
- → Arachnoid granulations (villi) → superior sagittal sinus (venous drainage)
Mnemonic: "Lateral Monro → 3rd → Sylvius → 4th → Luschka/Magendie → SAS → Granulations"
- Luschka = Lateral (both start with "L"); Magendie = Midline (both start with "M")
- CSF absorption is pressure-dependent — occurs when CSF pressure exceeds venous sinus pressure
The aqueduct of Sylvius is the narrowest segment of the ventricular system and the most common site of obstruction causing non-communicating (obstructive) hydrocephalus. Aqueductal stenosis can be congenital (X-linked L1CAM mutation) or acquired (tectal glioma, post-infection).
Normal CSF Values
| Parameter | Normal Value | Notes |
|---|---|---|
| Opening pressure | 10–20 cmH2O | Measured in lateral decubitus; >25 cmH2O = elevated |
| Appearance | Clear, colorless | Turbid if WBC >200 or bacteria present |
| Protein | 15–45 mg/dL | Higher in lumbar (>ventricular); neonates up to 150 mg/dL |
| Glucose | 60–70% of serum (>40 mg/dL) | Always compare with serum glucose drawn ~30 min prior |
| WBC | <5 lymphocytes/mm³ | No PMNs normally; neonates up to 20–30 WBC |
| RBC | 0 | If present → traumatic tap vs SAH (see xanthochromia) |
| Specific gravity | 1.006–1.009 | — |
| Chloride | 115–130 mEq/L | Higher than serum; ↓ in TB meningitis (historical marker) |
| IgG index | <0.7 | ↑ in MS and other intrathecal IgG production |
Traumatic tap vs SAH: in traumatic tap, RBC count decreases across sequential tubes; in SAH, RBC count remains constant across tubes. Xanthochromia (yellow supernatant from RBC lysis) is present in SAH (>6–12 hours) but absent in traumatic tap.
CSF in Disease — Master Comparison Table
| Condition | WBC | Cell Type | Glucose | Protein | Other Findings |
|---|---|---|---|---|---|
| Bacterial meningitis | ↑↑↑ (1000–10,000+) | PMNs (neutrophils) | ↓↓ (<40 mg/dL) | ↑↑ (>100 mg/dL) | Turbid; ↑ opening pressure; Gram stain/culture positive |
| Viral meningitis | ↑ (10–500) | Lymphocytes | Normal | Normal–↑ (50–100) | Clear; PCR for HSV, enterovirus; early PMNs may shift to lymphs |
| TB meningitis | ↑ (50–500) | Lymphocytes | ↓↓ | ↑↑ (100–500) | AFB smear (low sensitivity); adenosine deaminase (ADA) ↑; ↓ chloride |
| Fungal meningitis | ↑ (10–500) | Lymphocytes | ↓ | ↑↑ | India ink (Cryptococcus); cryptococcal Ag; ↑↑ opening pressure in Crypto |
| GBS | Normal (<10) | — | Normal | ↑↑ | Albuminocytologic dissociation (↑ protein, normal cells); may be normal first week |
| MS | Normal–mild ↑ | Lymphocytes | Normal | Normal–mild ↑ | Oligoclonal bands (present in CSF, absent in serum); ↑ IgG index; ↑ myelin basic protein |
| SAH | — | — | Normal | ↑ | Xanthochromia; ↑↑ RBC (uniform across tubes); ↑ opening pressure |
| Carcinomatous meningitis | ↑ | Lymphocytes + malignant cells | ↓ | ↑↑ | Positive cytology (may need repeated LPs); ↑ opening pressure |
| Neurosyphilis | ↑ (10–100) | Lymphocytes | Normal–↓ | ↑ | CSF VDRL (specific but insensitive); CSF FTA-ABS (sensitive) |
Albuminocytologic dissociation (elevated protein with normal cell count) is the hallmark CSF finding in GBS. It may be absent in the first week of illness. A similar pattern can be seen in spinal cord compression and diabetic radiculoplexopathy.
Key CSF Glucose Rules
- Low CSF glucose (↓) — bacterial, TB, fungal meningitis; carcinomatous meningitis; neurosarcoidosis; chemical meningitis
- Normal CSF glucose — viral meningitis, MS, GBS, neurosyphilis (usually)
- Mnemonic for ↓ glucose: "Bacteria and fungi EAT glucose"
Intracranial Pressure (ICP)
Normal Values & Concepts
- Normal ICP: 5–15 mmHg (7–20 cmH2O)
- Monro-Kellie doctrine: the cranial vault is a fixed volume; total volume of brain (~80%) + CSF (~10%) + blood (~10%) is constant → increase in one compartment requires decrease in another, or ICP rises
- Cerebral perfusion pressure (CPP): CPP = MAP − ICP (goal CPP >60 mmHg)
- ICP waveforms: P1 (percussion) > P2 (tidal) > P3 (dicrotic) is normal; if P2 > P1 → decreased compliance → impending herniation
Causes of Raised ICP
| Mechanism | Examples |
|---|---|
| ↑ Brain volume | Tumor, abscess, cerebral edema (cytotoxic or vasogenic), hemorrhage |
| ↑ CSF volume | Hydrocephalus (obstructive or communicating), choroid plexus papilloma |
| ↑ Blood volume | Venous sinus thrombosis, AVM, hypercarbia-induced vasodilation |
| Other | Idiopathic intracranial hypertension (IIH), meningitis |
ICP Management Principles
- Head elevation — 30 degrees (improves venous drainage)
- Hyperosmolar therapy — mannitol (osmotic diuretic) or hypertonic saline
- Hyperventilation — acute only; ↓ PaCO2 → cerebral vasoconstriction → ↓ ICP (target PaCO2 30–35 mmHg; avoid prolonged use)
- CSF drainage — EVD (external ventricular drain)
- Surgical — decompressive craniectomy for refractory raised ICP
Hydrocephalus
Communicating vs Obstructive (Non-Communicating)
| Feature | Communicating | Obstructive (Non-Communicating) |
|---|---|---|
| Obstruction site | Outside ventricular system (arachnoid granulations or subarachnoid space) | Within ventricular system |
| All ventricles dilated? | Yes (all ventricles communicate) | Ventricles proximal to obstruction are dilated |
| Common causes | Post-SAH, post-meningitis, carcinomatous meningitis, venous sinus thrombosis | Aqueductal stenosis, colloid cyst (3rd ventricle), posterior fossa tumor (4th ventricle), Chiari malformation |
| Treatment | VP shunt (ventriculoperitoneal) | Treat obstruction; ETV (endoscopic third ventriculostomy); VP shunt |
Specific Hydrocephalus Locations
| Obstruction Site | Ventricles Dilated | Classic Cause |
|---|---|---|
| Foramen of Monro | One lateral ventricle (unilateral) | Colloid cyst, subependymal giant cell astrocytoma (tuberous sclerosis) |
| Aqueduct of Sylvius | Both lateral + 3rd ventricle | Aqueductal stenosis, tectal glioma, pineal tumor |
| 4th ventricle outlets | All four ventricles | Posterior fossa tumor (medulloblastoma in children, ependymoma), Dandy-Walker malformation |
Normal Pressure Hydrocephalus (NPH)
- Type: communicating hydrocephalus with intermittently elevated ICP
- Demographics: elderly (usually >60 years)
- Classic triad (wet–wacky–wobbly):
- Gait apraxia (magnetic gait) — first and most responsive to treatment
- Dementia (subcortical pattern)
- Urinary incontinence — last to appear
- Diagnosis: ventriculomegaly on imaging out of proportion to sulcal atrophy; large-volume LP (>30 mL) with gait improvement
- Treatment: VP shunt or LP shunt
In NPH, gait disturbance is the FIRST symptom to appear and the MOST responsive to shunting. The classic "magnetic gait" (feet stuck to the floor, wide-based, short shuffling steps) distinguishes NPH from Parkinson's disease. A large-volume LP with gait improvement predicts shunt responsiveness.
Idiopathic Intracranial Hypertension (IIH) / Pseudotumor Cerebri
- Demographics: young, obese women of childbearing age
- Symptoms: headache (worse with Valsalva), transient visual obscurations, pulsatile tinnitus, diplopia (CN VI palsy — false localizing sign)
- Exam: papilledema (bilateral); enlarged blind spot; visual field loss
- Imaging: empty sella, flattened posterior sclera, dilated optic nerve sheaths, transverse venous sinus stenosis; no mass lesion
- LP: opening pressure >25 cmH2O; CSF composition normal
- Modified Dandy criteria: symptoms of raised ICP, papilledema, normal CSF, ↑ opening pressure, no other cause
- Treatment: weight loss, acetazolamide (first-line), topiramate, optic nerve sheath fenestration or shunt (if vision threatened)
- Medications that worsen/cause IIH: vitamin A (retinoids), tetracyclines, growth hormone, corticosteroid withdrawal
CN VI palsy in the setting of raised ICP is a false localizing sign — it results from stretching of the abducens nerve over the petrous ridge due to downward displacement of the brainstem, not a focal lesion. It can occur in IIH, hydrocephalus, or any cause of diffusely elevated ICP.
Blood-Brain Barrier (BBB)
Structure
- Three layers:
- Endothelial cells with tight junctions (zonula occludens) — the primary barrier; lack fenestrations; low pinocytic activity
- Basement membrane — provides structural support; contains pericytes (regulate BBB permeability)
- Astrocyte foot processes (end-feet) — surround >99% of capillary surface; maintain BBB integrity and induce tight junction formation
- Note: the BBB exists at cerebral capillaries, NOT at the choroid plexus (which has the blood-CSF barrier instead)
What Crosses the BBB?
| Crosses BBB | Does NOT Cross BBB |
|---|---|
| Lipophilic molecules (O2, CO2, ethanol, anesthetics) | Hydrophilic/polar molecules |
| Small molecular weight (<400–500 Da) | Large proteins (albumin, immunoglobulins) |
| Uncharged/non-ionized forms | Ionized/charged molecules |
| Glucose (via GLUT1 transporter) | Dopamine (but L-DOPA crosses via LNAA transporter) |
| L-DOPA (via large neutral amino acid transporter) | Most antibiotics (exception: metronidazole, chloramphenicol, rifampin, fluoroquinolones cross well) |
| Nicotine, caffeine, heroin, diazepam | Penicillin, vancomycin (unless inflamed meninges) |
Key Transporters
- GLUT1 — glucose transporter; insulin-independent; GLUT1 deficiency syndrome → seizures, microcephaly, low CSF glucose (CSF:serum glucose ratio <0.4)
- Large neutral amino acid transporter (LNAA/LAT1) — transports L-DOPA, phenylalanine, tryptophan; basis for giving L-DOPA (crosses BBB) instead of dopamine (does not cross)
- P-glycoprotein (MDR1) — efflux pump on endothelial cells; pumps drugs OUT of CNS; contributes to drug-resistant epilepsy
Dopamine does NOT cross the BBB, but its precursor L-DOPA does (via the large neutral amino acid transporter). This is why Parkinson's disease is treated with L-DOPA (+ carbidopa to prevent peripheral decarboxylation) rather than dopamine itself. GLUT1 deficiency syndrome should be suspected in a child with refractory seizures and low CSF glucose — treated with a ketogenic diet.
Circumventricular Organs (CVOs) — Regions that LACK a BBB
| Circumventricular Organ | Location | Function |
|---|---|---|
| Area postrema | Floor of 4th ventricle | Chemoreceptor trigger zone (emesis); detects blood-borne toxins/emetics |
| Median eminence | Hypothalamus (base) | Hypothalamic-pituitary hormone release |
| Neurohypophysis (posterior pituitary) | Sella turcica | Release of ADH and oxytocin into blood |
| Pineal gland | Posterior 3rd ventricle | Melatonin secretion |
| Subfornical organ (SFO) | Anterior 3rd ventricle | Senses angiotensin II; regulates thirst and vasopressin release |
| OVLT (organum vasculosum of lamina terminalis) | Anterior 3rd ventricle | Senses osmolality and cytokines (fever response); thirst regulation |
| Subcommissural organ | Posterior 3rd ventricle | Secretes SCO-spondin; involved in CSF flow |
Mnemonic for CVOs: "AM-PONS" — Area postrema, Median eminence, Pineal, OVLT, Neurohypophysis, Subfornical organ
The area postrema lacks a BBB — this allows it to detect circulating toxins and drugs, triggering emesis. This is why chemotherapy-induced nausea involves the area postrema. 5-HT3 antagonists (ondansetron) block serotonin at this site.
BBB Disruption
Causes & Clinical Significance
| Cause of BBB Disruption | Mechanism | Clinical Example |
|---|---|---|
| Infection / inflammation | Cytokines, proteases disrupt tight junctions | Meningitis (allows antibiotics to penetrate better); encephalitis |
| Tumors | Tumor neovasculature lacks normal tight junctions | Ring-enhancing lesion on MRI (GBM, metastases, abscess) |
| Ischemia / stroke | Energy failure → endothelial damage | Hemorrhagic transformation after reperfusion; vasogenic edema |
| Hypertensive encephalopathy (PRES) | Exceeds autoregulatory capacity → forced vasodilation → BBB breakdown | Posterior reversible encephalopathy syndrome (PRES); posterior predilection (less sympathetic innervation) |
| MS (active plaque) | Immune-mediated breakdown; T-cell migration across BBB | Gadolinium-enhancing lesions indicate active BBB breakdown |
| Osmotic demyelination | Rapid correction of hyponatremia → endothelial damage | Central pontine myelinolysis |
- MRI contrast enhancement (gadolinium) — gadolinium does NOT cross an intact BBB; enhancement = BBB breakdown
- Vasogenic edema — BBB disruption → plasma proteins leak into extracellular space → white matter edema (responds to steroids)
- Cytotoxic edema — cell swelling due to energy failure (ischemic stroke); BBB initially intact; does NOT respond to steroids
Vasogenic vs cytotoxic edema: Vasogenic edema (BBB breakdown, affects white matter, responds to steroids — seen in tumors) must be distinguished from cytotoxic edema (cell swelling, affects gray matter, does NOT respond to steroids — seen in acute ischemic stroke). DWI-bright lesions in stroke represent cytotoxic edema (restricted diffusion).
Drugs: BBB Penetration
| Good BBB Penetration | Poor BBB Penetration (crosses with inflamed meninges) | Poor BBB Penetration (does not cross well even with inflammation) |
|---|---|---|
| Metronidazole | Penicillin / ampicillin | Aminoglycosides (gentamicin) |
| Chloramphenicol | Vancomycin | First-gen cephalosporins |
| Rifampin | 3rd-gen cephalosporins (ceftriaxone) | Clindamycin |
| Fluoroquinolones | Meropenem | — |
| TMP-SMX | Amphotericin B | — |
| Isoniazid, pyrazinamide | — | — |
Lumbar Puncture (LP)
Indications
- Suspected meningitis or encephalitis
- Subarachnoid hemorrhage (if CT negative)
- Measurement of opening pressure (IIH, NPH)
- Therapeutic removal of CSF (IIH, NPH evaluation)
- Intrathecal drug administration (chemotherapy, baclofen, anesthesia)
- Diagnosis of MS, GBS, neurosyphilis, carcinomatous meningitis
Contraindications
- Absolute: intracranial mass with midline shift or risk of herniation; skin infection at puncture site
- Relative: coagulopathy (INR >1.5, platelets <50,000); therapeutic anticoagulation; raised ICP without imaging
- When to image before LP: immunocompromised, history of CNS disease, new-onset seizures, papilledema, focal neurological deficit, altered consciousness
Technique
- Position: lateral decubitus (for accurate opening pressure) or sitting
- Level: L3–L4 or L4–L5 interspace (below the conus medullaris, which ends at ~L1–L2 in adults)
- Landmark: iliac crest line = approximately L4 spinous process
- Layers traversed: skin → subcutaneous tissue → supraspinous ligament → interspinous ligament → ligamentum flavum → epidural space → dura mater → arachnoid mater → subarachnoid space
Complications
| Complication | Details |
|---|---|
| Post-LP headache | Most common (~10–30%); positional (worse upright, better supine); due to CSF leak; risk factors: young, female, large needle; Tx: caffeine, epidural blood patch; use atraumatic needle to ↓ risk |
| Herniation | Rare but fatal; risk with posterior fossa mass or midline shift; always image first if concerned |
| CSF leak / fistula | Persistent leak from dural tear |
| Back pain | Usually self-limited |
| Epidermoid tumor | Rare; from implantation of skin cells if needle lacks stylet |
| Infection / epidural abscess | Rare; due to poor sterile technique |
Post-LP headache is caused by ongoing CSF leak through the dural puncture site, leading to low CSF pressure and traction on pain-sensitive meningeal structures. Using an atraumatic (pencil-point/Sprotte) needle reduces the risk compared to a cutting (Quincke) needle. First-line treatment for persistent post-LP headache is an epidural blood patch.
Quick Reference — Summary Table
| Topic | Key Fact |
|---|---|
| CSF volume | ~150 mL total; produced at ~20 mL/hr (~500 mL/day); turned over 3–4×/day |
| CSF production | Choroid plexus (70%), brain parenchyma (30%); active secretion; acetazolamide ↓ production |
| Narrowest point | Aqueduct of Sylvius — most common site of obstructive hydrocephalus |
| CSF absorption | Arachnoid granulations → superior sagittal sinus; pressure-dependent |
| Luschka vs Magendie | Luschka = Lateral (2); Magendie = Midline (1) |
| Normal opening pressure | 10–20 cmH2O |
| CPP equation | CPP = MAP − ICP; goal >60 mmHg |
| NPH triad | Gait apraxia (first/most treatable) → dementia → urinary incontinence (last) |
| IIH | Young obese women; papilledema; empty sella; normal CSF; ↑ opening pressure; Tx: weight loss + acetazolamide |
| BBB structure | Endothelial tight junctions + basement membrane + astrocyte foot processes |
| BBB crossing | Lipophilic, small (<400 Da), uncharged molecules; GLUT1 (glucose), LNAA (L-DOPA) |
| CVOs (no BBB) | Area postrema, median eminence, neurohypophysis, pineal, subfornical organ, OVLT |
| Contrast enhancement | Gadolinium does NOT cross intact BBB; enhancement = BBB breakdown |
| Vasogenic vs cytotoxic edema | Vasogenic: BBB breakdown, white matter, responds to steroids; Cytotoxic: cell swelling, gray matter, no steroid response |
| LP level | L3–L4 or L4–L5 (below conus at L1–L2) |
| Post-LP headache | Positional; Tx: epidural blood patch; prevent with atraumatic needle |
| Albuminocytologic dissociation | ↑ protein, normal cells = GBS |
| Oligoclonal bands | Present in CSF but not serum = MS |
| Xanthochromia | Yellow supernatant = SAH (>6–12 hrs old); absent in traumatic tap |
References
- Bhatt A. Ultimate Review for the Neurology Boards. 3rd ed. Demos Medical; 2016. Chapter 1: Neuroscience.
- Blumenfeld H. Neuroanatomy Through Clinical Cases. 3rd ed. Sinauer Associates; 2021.
- Ropper AH, Samuels MA, Klein JP, Prasad S. Adams and Victor's Principles of Neurology. 12th ed. McGraw-Hill; 2023.
- Waxman SG. Clinical Neuroanatomy. 29th ed. McGraw-Hill; 2020.
- Fishman RA. Cerebrospinal Fluid in Diseases of the Nervous System. 2nd ed. Saunders; 1992.